Champion AF

The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Contact phone
Sparrow Clinical Research Institute 517.364.5760
Principal investigator
Nam Cho, D.O.
Trial Category
Heart & Vascular
Trial SubCategory
Atrial Fibrillation